Hanford recently acquired approximately 84,000 square feet of undeveloped space that we are currently developing into a non-beta lactam manufacturing facility.

This facility will enable Hanford to apply all of our manufacturing and pharmaceutical support experience to the manufacture of a broader range of products.

Our new facility is being designed as a general pharmaceutical manufacturing facility so as to give our clients ample opportunity to customize their space and equipment to exact specifications.

Clients can partner with Hanford so that they can leverage our production management, support, quality and regulatory experience in a setting developed to meet their specific needs.

Manufacturing space for both sterile and non-sterile products will be developed and a modular approach will be used to ensure maximum flexibility and ease of conversion.

The facility will be spacious enough to accommodate pilot and clinical scale manufacturing as well as full-scale commercial production.

Hanford can apply our knowledge and experience to meet specific customer needs and we can tailor our level of support to meet customer requirements. We can also make space available to customers who need space in which their own product development and manufacturing specialists can work.

Hanford can supply as much or as little support as each client requires and we can do so within a full GMP setting.